Abstract
Thoracic aortic aneurysm and dissection (TAAD) is a life-threatening condition associated with Marfan syndrome (MFS), a disease caused by fibrillin-1 gene mutations. While various conditions causing TAAD exhibit aortic accumulation of the proteoglycans versican (Vcan) and aggrecan (Acan), it is unclear whether these ECM proteins are involved in aortic disease. Here, we find that Vcan, but not Acan, accumulated in Fbn1 C1041G/+ aortas, a mouse model of MFS. Vcan haploinsufficiency protected MFS mice against aortic dilation, and its silencing reverted aortic disease by reducing Nos2 protein expression. Our results suggest that Acan is not an essential contributor to MFS aortopathy. We further demonstrate that Vcan triggers Akt activation and that pharmacological Akt pathway inhibition rapidly regresses aortic dilation and Nos2 expression in MFS mice. Analysis of aortic tissue from MFS human patients revealed accumulation of VCAN and elevated pAKT-S473 staining. Together, these findings reveal that Vcan plays a causative role in MFS aortic disease in vivo by inducing Nos2 via Akt activation and identify Akt signaling pathway components as candidate therapeutic targets.
Funding Information
  • Ministerio de Ciencia e Innovación (PID2021-122388OB-100)
  • Ministerio de Ciencia e Innovación (PID2020-115217RB-100)
  • Ministerio de Ciencia e Innovación (RTI2018-099246-B-I00)
  • Ministerio de Ciencia e Innovación (CEX2021-001154-S)
  • Ministerio de Ciencia e Innovación (CEX2020-001041-S)
  • Ministerio de Ciencia e Innovación (BES-2016-077649)
  • Ministerio de Ciencia e Innovación (CD18/00028)
  • Ministerio de Ciencia e Innovación (IJC2020-044581-I)
  • Ministerio de Ciencia e Innovación (RYC2021-033343-I)
  • 'la Caixa' Foundation (HR18-00068)
  • Instituto de Salud Carlos III (CB16/11/00264)
  • Instituto de Salud Carlos III (CB16/11/00479)
  • Instituto de Salud Carlos III (PI17/00381)
  • Instituto de Salud Carlos III (PI21/00084)
  • Fundació la Marató de TV3 (20151330)
  • Instituto de Investigación Marqués de Valdecilla (INNVAL 21/24)
  • Marfan Foundation (MRF/1701)
  • Fundacion MERCK-Fundacion Espanola de Enfermedades Raras (Muévete por los que no pueden 2021)
  • Ministerio de Universidades (FPU 20/04814)

This publication has 57 references indexed in Scilit: